Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pre-50S ribosomal subunit intermediates are transient ribonucleoprotein complexes formed during the hierarchical assembly of the bacterial large (50S) ribosomal subunit (Shajani et al., 2011, Annual Review of Biochemistry). This process involves the coordinated folding of 23S and 5S rRNAs and the sequential binding of approximately 33 ribosomal proteins, often facilitated by specialized assembly factors such as GTPases and RNA helicases (Davis & Williamson, 2017, Nature). These intermediates serve as critical checkpoints in ribosome biogenesis, ensuring that only correctly folded and processed subunits enter the translation cycle. In the context of pharmacology, several classes of antibiotics, including macrolides and pleuromutilins, have been shown to interfere with the late stages of 50S maturation, causing the accumulation of defective pre-50S particles (Champney, 2006, Current Drug Targets). Targeting these intermediates or their associated assembly factors represents a potent strategy for developing new antimicrobial agents, as it disrupts the production of the protein synthesis machinery itself (Dunkle et al., 2010, Science). Such disruption leads to a rapid decline in cellular translation capacity and eventual bacterial cell death. Furthermore, the structural differences between bacterial pre-50S intermediates and eukaryotic ribosome precursors provide a window for therapeutic selectivity.
Inhibition of ribosomal subunit assembly and maturation, leading to the accumulation of non-functional precursor particles and depletion of active 70S ribosomes.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pre-50S ribosomal subunit intermediate (Pre-50S) (Pre-50S).